2348 Trastuzumab with triple chemotherapy (DOC-T) in patients with advanced gastro-esophageal cancer. A phase I/II study. (September 2015) - Pfeiffer, P.; Yilmaz, M.; Bæksgaard, L.; Schønnemann, K.R.; Krogh, M.; Qvortrup, C.; Bjerregaard, J.K.; Jensen, H.A.; Vestermark, L.W.